Citius Oncology CTOR
NASDAQ CTOR
$0.70 +0.03 (+4.37%)
At close: Oct 21, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Total Non-Current Liabilities (2024 - 2026)

Updated

Citius Oncology (CTOR) reported Total Non-Current Liabilities of $64.87 million for fiscal Q2 2026 (quarter ended Mar 31, 2026), up 17.4% from $55.24 million a year earlier and up 27.2% from the prior quarter.

Analysis

Citius Oncology (CTOR) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Citius Oncology posted Total Non-Current Liabilities of $55.52 million.

  • Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $51 million (Q1 2026), $55.52 million (Q4 2025) and $58.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Citius Oncology 72.00 Mn 41.58 Mn 1.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 64.87 Mn
Dec 31, 2025 51.00 Mn
Sep 30, 2025 55.52 Mn
Jun 30, 2025 58.75 Mn
Mar 31, 2025 55.24 Mn
Dec 31, 2024 48.63 Mn
API Access

Citius Oncology Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CTOR&period=max&api_key=YOUR_API_KEY